🚨⭐️Living Guidelines for Tumor-Agnostic Therapies: A Pathway to Next-Generation Cancer Treatment | JCO Precision Oncology JCO Precision Oncology ASCO OncoAlert ascopubs.org/doi/10.1200/PO…

European Society of Neuroendocrine Tumors (ENETS) 2025 guidance paper for lung and thymic carcinoids - Baudin - 2026 - Journal of Neuroendocrinology - Wiley Online Library ⁦Grupo GETNE⁩ ⁦Vall d’Hebron Institute of Oncology (VHIO)⁩ ⁦Vall d'Hebron⁩ ⁦NET- ESPAÑA⁩ onlinelibrary.wiley.com/doi/10.1111/jn…

ctDNA vs pCR in early breast cancer (HER2+/TNBC) Prospective PREDICT-DNA study shows: • ctDNA after neoadjuvant therapy does NOT reliably predict pCR (NPV 60%) • But it is a powerful prognostic marker Key signals: • Post-NAT ctDNA+ → ↑ recurrence risk (HR 8.9) •

Hoy es el Dia Mundial de la Salud, fecha que conmemora la creación de la OMS. En su 77 aniversario, el lema es "Juntos por la salud. Respaldemos la ciencia" (“Together for Health. Stand with Science”), que pone en valor la ciencia y la salud. global.

PTEN loss and the future of precision treatment in #mHSPC. Karim Fizazi, MD, PhD Gustave Roussy & Noel Clarke, MBBS, FRCS, ChM The Christie NHS join Neeraj Agarwal, MD, FASCO Huntsman Cancer Institute to discuss CAPItello-281 results and the emerging need for routine biomarker testing in metastatic

Brilliant work by my colleague and friend Dr. Maria Vieito. Exciting results with next-generation BRAF inhibitors in Journal of Clinical Oncology

Last week I was on Good Morning America talking about one of my own patients, a 26-year-old who is now cancer-free. Being part of her care is something I won’t forget. Her outcome wasn’t luck. It came from understanding the biology, biomarker testing, and choosing treatment

ADCs for non-oncology indications? Preclinical paper describing the discovery, optimization, and development of AMG 133 out on #JMedChem ACS Publications Bio & Med Chem Content AMG 133 (maridebart cafraglutide) = anti-GIPR-Ab conjugated to a synthetic GLP-1 peptide! pubs.acs.org/doi/10.1021/ac…

💪Estar en forma pot prevenir +30 malalties🦠 👩‍🔬L'equip de recerca ho demostra amb evidència científica 💙Més exercici = més salut 📰Llegeix: hospitaldelmar.cat/ca/noticies/vi… Álvaro Hernáez (alvarohernaez.bsky.social) U. Ramon Llull (URL) Blanquerna HMar Research Institute

💎The Library of BEUCEA, designed by TJAD, serves as the heart of the campus, highlighting the cultural importance of its location.

⚡️ In BCG-naïve high-risk NMIBC, immunotherapy escalation is promising—but not for everyone. BCG remains a highly effective benchmark, and any added benefit must be balanced against immune toxicity, cost, and the risk of overtreatment. Selectivity matters. #BladderCancer

🏃‍♂️ Juntos contra el #CáncerdeVejiga El domingo 19 de abril estaremos en Madrid, en la XII Carrera Asociación Española Contra el Cáncer, con una carpa de apoyo a pacientes con tumores GU. 👉 Detectarlo a tiempo salva vidas Nos vemos en Espacio Colón.  Con el apoyo institucional de CANVES Alianza por el Cáncer de Vejiga en España

🏛️Encuentro Día Mundial del Cáncer de Colon | Europa Press Takeda Oncology. Participan: 👉Dra. Elena Élez, Vall d’Hebron Institute of Oncology (VHIO) 👉Dr. Íñigo Martínez, Hospital Ramón y Cajal 👉Luis Miguel de la Fuente EuropaColon España 👉Pilar Fernández Pascual, ALMIA Cáncer Metastásico cancermetastasico.es/encuentro-dia-…

Top #GICancer Oncologists for Q1 2026, curated by LARVOL CLIN based on most viewed 𝕏 posts. Explore more about oncology conferences, top trials, and reactions from oncologists: clin.larvol.com 👇🏻

Top Women Oncologists for Q1 2026, curated by LARVOL CLIN based on most viewed 𝕏 posts. Explore more about oncology conferences, top trials, and reactions from oncologists: clin.larvol.com #LARVOL #Oncology #CancerResearch #CancerData #OncologyInsights #ClinicalTrials

🤰 Cancer during pregnancy: ASCO Guideline at Journal of Clinical Oncology! ascopubs.org/doi/10.1200/JC… 🎯 Multidisciplinary, patient-centered decision-making 📸 Imaging: follow ALARA principle ☝🏼 Systemic therapy → avoid 1st trimester; consider from 2nd 🛑 Contraindicated: MTX, anti-HER2, VEGF

La UE define el reglamento del Consejo del Espacio de Datos de Salud: cooperación, transparencia y gobernanza para un sistema sanitario digital más seguro y eficiente. 🏥💻🔐 diariofarma.com/2026/04/08/eur…

Boehringer, BioNTech to pair DLL3-targeting with PD-L1/VEGF in lung cancer | FirstWord Pharma firstwordpharma.com/story/7175698

Noelia Tarazona (incliva), Premio CRIS por innovación en cáncer de colon elperiodic.com/valencia/noeli…

Despite data concerns, Roche’s oral SERD can still be largest product in company history: exec | Fierce Biotech fiercepharma.com/pharma/roche-p…